Connection

JOSEPH MILLS to Hydroxymethylglutaryl-CoA Reductase Inhibitors

This is a "connection" page, showing publications JOSEPH MILLS has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
  1. Using a Markov Model and Real-World Evidence to Identify the Most Cost-Effective Cholesterol Treatment Escalation Threshold for the Secondary Prevention of Cardiovascular Disease. Appl Health Econ Health Policy. 2025 Sep; 23(5):869-883.
    View in: PubMed
    Score: 0.142
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.